Osteoarthritis (OA) is the most prevalent degenerative joint disease and is accompanied by pain and joint dysfunction. Its clinical treatment tends to be unsatisfactory. Novel targets in OA include genes that are involved in OA pathophysiology and have been discovered using gene network, epigenetic and microRNA (miRNA) approaches. miRNA has been implicated in important cellular processes such as lipid metabolism, apoptosis, differentiation and organ development. The importance of miRNA regulation in cellular function is becoming increasingly clear as new miRNA targets are revealed. The present review summarizes the current evidence of the important role played by miRNA in determining the complex gene expression patterns of OA chondrocytes and their role in the regulation of transcription, and possible demethylation mechanisms that might be applicable in OA. In summary, miRNA may have important diagnostic and therapeutic potential, and might provide a novel means of treating OA.
PottiePPresleNTerlainB: Obesity and osteoarthritis: More complex than predicted!Ann Rheum Dis2006; 65: 1403–1405.
2.
ShamoonMHochbergMC: Treatment of osteoarthritis with acetaminophen: Efficacy, safety, and comparison with nonsteroidal anti- inflammatory drugs. Curr Rheumatol Rep2000; 2: 454–458.
3.
JukicćAKaliternaDMRadiM: Nonsteroidal anti-inflammatory drugs and the risk of cardiovascular diseases. Reumatizam2010; 57: 26–28 [in Croatian, English abstract].
4.
GoldringMBGoldringSR: Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann NY Acad Sci2010; 1192: 230–237.
5.
LiXWuJF: Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs). Recent Pat Anticancer Drug Discov2010; 5: 109–141.
6.
LittleCBBaraiABurkhardtD: Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum2009; 60: 3723–3733.
7.
GooljarsinghLTLakdawalaACoppoF: Characterization of an exosite binding inhibitor of matrix metalloproteinase 13. Protein Sci2008; 17: 66–71.
8.
GilbertAMBursavichMGLombardiS: N-((8-Hydroxy-5-substituted-quinolin-7-yl) (phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2). Bioorg Med Chem Lett2009; 18: 6454–6457.
9.
WittwerAJHillsRLKeithRH: Substrate-dependent inhibition kinetics of an active site-directed inhibitor of ADAMTS-4 (Aggrecanase 1). Biochemistry2007; 46: 6393–6401.
10.
TortorellaMDTomasselliAGMathisKJ: Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors. J Biol Chem2009; 284: 24185–24191.
11.
AlcarazMJMegíasJGarcía-ArnandisI: New molecular targets for the treatment of osteoarthritis. Biochem Pharmacol2010; 80: 13–21.
12.
EsauCDavisSMurraySF: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab2006; 3: 87–98.
13.
HeLHeXLoweSW: microRNAs join the p53 network–another piece in the tumour-suppression puzzle. Nat Rev Cancer2007; 7: 819–822.
CallisTEChenJFWangDZ: MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol2007; 26: 219–225.
16.
CalinGACroceCM: MicroRNA signatures in human cancers. Nat Rev Cancer2006; 6: 857–866.
17.
LeeRCFeinbaumRLAmbrosV: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell1993; 75: 843–854.
18.
WightmanBHaIRuvkunG: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell1993; 75: 855–862.
19.
Griffiths-JonesS: The microRNA Registry. Nucleic Acids Res2004; 32: D109–D111.
LewisBPBurgeCBBartelDP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell2005; 120: 15–20.
22.
DiederichsSHaberDA: Sequence variations of microRNAs in human cancer: Alterations in predicted secondary structure do not affect processing. Cancer Res2006; 66: 6097–6104.
23.
YanaiharaNCaplenNBowmanE: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell2006; 9: 189–198.
24.
LeeYAhnCHanJ: The nuclear RNase III Drosha initiates microRNA processing. Nature2003; 425: 415–419.
25.
WinterJJungSKellerS: Many roads to maturity: Microrna biogenesis pathways and their regulation. Nat Cell Biol2009; 11: 228–234.
26.
Lagos-QuintanaMRauhutRLendeckelW: Identification of novel genes coding for small expressed RNAs. Science2001; 294: 853–858.
27.
LauNCLimLPWeinsteinEG: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science2001; 294: 858–862.
28.
LeeRCAmbrosV: An extensive class of small RNAs in Caenorhabditis elegans. Science2001; 294: 862–864.
29.
ZengYCullenBR: Sequence requirements for micro RNA processing and function in human cells. RNA2003; 9: 112–123.
30.
MendellJT: miRiad roles for the miR-17-92 cluster in development and disease. Cell2008; 133: 217–222.
31.
BartelDP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell2004; 116: 281–297.
32.
WuLBelascoJG: Let me count the ways: Mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell2008; 29: 1–7.
33.
LiuJCarmellMARivasFV: Argonaute2 is the catalytic engine of mammalian RNAi. Science2004; 305: 1437–1441.
34.
MathonnetGFabianMRSvitkinYV: MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science2007; 317: 1764–1767.
35.
OkamuraKIshizukaASiomiH: Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways. Genes Dev2004; 18: 1655–1666.
36.
ZamorePDTuschlTSharpPA: RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell2000; 101: 25–33.
37.
LlaveCXieZKasschauKD: Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science2002; 297: 2053–2056.
38.
YektaSShihIHBartelDP: MicroRNA-directed cleavage of HOXB8 mRNA. Science2004; 304: 594–596.
ThaiTHCaladoDPCasolaS: Regulation of the germinal center response by microRNA-155. Science2007; 316: 604–608.
41.
CobbBSNesterovaTBThompsonE: T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med2005; 201: 1367–1373.
42.
KanellopoulouCMuljoSAKungAL: Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev2005; 19: 489–501.
43.
IliopoulosDMalizosKNOikonomouP: Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One2008; 3: e3740.
44.
JonesSWWatkinsGLe GoodN: The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-α and MMP13. Osteoarthritis Cartilage2009; 17: 464–472.
45.
MiyakiSSatoTInoueA: MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev2010; 24: 1173–1185.
46.
TuddenhamLWheelerGNtounia-FousaraS: The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett2006; 580: 4214–4217.
47.
MiyakiSNakasaTOtsukiS: MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum2009; 60: 2723–2730.
48.
TardifGHumDPelletierJP: Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord2009; 10: 148.
49.
KimSYKimAYLeeHW: miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression. Biochem Biophys Res Commun2010; 392: 323–328.
50.
FelsonDTAndersonJJNaimarkA: Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med1988; 109: 18–24.
51.
OliveriaSAFelsonDTCirilloPA: Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology1999; 10: 161–166.
52.
KershawEEFlierJS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab2004; 89: 2548–2556.
53.
AkhtarNRasheedZRamamurthyS: MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum2010; 62: 1361–1371.
54.
OhgawaraTKubotaSKawakiH: Regulation of chondrocytic phenotype by micro RNA 18a: Involvement of Ccn2/Ctgf as a major target gene. FEBS Lett2009; 583: 1006–1010.
55.
PerbalB: The CCN family of cell growth regulators: A new family of normal and pathologic cell growth and differentiation regulators: Lessons from the first international workshop on CCN gene family. Bull Cancer2001; 88: 645–649 [in French].
56.
TakigawaMNakanishiTKubotaS: Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol2003; 194: 256–266.
57.
IvkovicSYoonBSPopoffSN: Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development2003; 130: 2779–2791.
58.
NakanishiTNishidaTShimoT: Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology2000; 141: 264–273.
59.
NishidaTKubotaSNakanishiT: CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes. J Cell Physiol2002; 192: 55–63.
60.
TaganovKDBoldinMPChangKJ: NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA2006; 103: 12481–12486.
61.
YamasakiKNakasaTMiyakiS: Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum2009; 60: 1035–1041.
62.
AbouheifMMNakasaTShibuyaH: Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. Rheumatology (Oxford)2010; 49: 2054–2060.
63.
BazzoniFRossatoMFabbriM: Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA2009; 106: 5282–5287.
64.
DudekKALafontJEMartinez-SanchezA: Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes. J Biol Chem2010; 285: 24381–24387.
65.
DunnWDuRaineGReddiAH: Profiling microRNA expression in bovine articular cartilage and implications for mechanotransduction. Arthritis Rheum2009; 60: 2333–2339.
66.
RoachHIAignerT: DNA methylation in osteoarthritic chondrocytes: A new molecular target. Osteoarthritis Cartilage2007; 15: 128–137.
67.
da SilvaMAYamadaNClarkeNM: Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J Orthop Res2009; 27: 593–601.
68.
WuLZhouHZhangQ: DNA methylation mediated by a microRNA pathway. Mol Cell2010; 38: 465–475.
